Boardroom Media (CFO News)
At CFO (Boardroom Media) we track over 1,000,000 startups and over 5,000,000 people who hold key positions in these companies. We use this directory of startups to highlight top employees, founders and board members we think deserve more appreciation than they are currently getting.
This list showcases the top United States based CFO’ operating in the Medical Device space. If you think a CFO’ is missing from this list, feel free to contact our editor on [email protected].
The individuals on this list have been included because of exceptional performance in one of the following categories:
- Innovation – Operating as a key part in an extremely innovative business or startup.
- Growth – Operating as a key figure in the growth and upscale of a market leading business or startup.
- Management – Showing exceptional management skills.
- Societal impact – Putting their business on the map for their positive societal or environmental impact.
Our Data – We source our data from OSINT (open source intelligence) and public directories such as Crunchbase, SemRush and many more. The data from these sources should be treated with a degree of caution and verified yourself.
Thomas Antonio
Vice President of Financial & CFO of Drive Medical
Thomas Antonio joined the Company in February 2004, and is primarily responsible for financial reporting. From 1986 through 1997, Thomas Antonio served as the Assistant Vice President and Controller of Charan Industries, a privately-held company which owned and operated bowling centers throughout the United States. From 1997 through February 2004, Thomas served as the Chief Financial Officer of several privately-held companies located in the metropolitan New York area.
Follow Thomas Antonio:
About Drive Medical: Drive Medical is one of the fastest growing global distributors of durable medical equipment.
Lee Kalowski
Chief Financial Officer of Bicycle Therapeutics
Lee has served as chief financial officer at Tokai since September 2014. Prior to joining Tokai, he served as a vice president in global biotechnology equity research at Credit Suisse. In this role, Lee served as a senior research analyst covering the biotechnology industry, including numerous companies globally in the prostate cancer therapeutic area. Prior to Credit Suisse, Lee worked at Johnson & Johnson in mergers & acquisitions in the pharmaceutical group, where he was involved in the analysis and execution of several completed transactions, and in global pharmaceutical equity research at Sanford C. Bernstein and Prudential Equity Group. Lee holds a B.A., Phi Beta Kappa, in biology and economics, from Union College and an M.B.A. in finance and health care management from the Wharton School, University of Pennsylvania.
Follow Lee Kalowski:
About Bicycle Therapeutics: Bicycle Therapeutics is developing a technology for the creation of new generation biotherapeutics.
Sailesh R. Saxena
CFO of ReliantHeart
Mr. Saxena is the Chief Financial Officer and Co-Founder of ReliantHeart. He played a critical role in the acquisition of the HeartAssist5 technology. He has more than twenty-five years of leadership and consulting experience in financial services, supply chain management, information technology, research and development, and operations. He has worked with numerous private equity fund companies providing financial consulting and analysis on transactions to raise capital for acquisition or investment projects. He has an MBA from SMU Cox School of Business and Electrical engineering degree from Birla Institute of Technology and Science, Pilani (BITS), India.
Follow Sailesh R. Saxena:
About ReliantHeart: ReliantHeart, Inc. is a leading innovator in mechanical circulatory support therapies for advanced stage heart failure.
Gene Castagnini
COO, CFO, CAO & Co-founder of Biocare Medical
Gene J. Castagnini, MS, MBA, co-founded Biocare Medical LLC in 1997 and serves as its Co-Owner and Chief Financial Officer. Gene Castagnini serves as the Chief Operating Officer and Executive Vice President of Biocare Medical, LLC Gene Castagnini served as the Chief Administrative Officer and Chief Financial Officer of BioGenex Laboratories. Inc., for 10 years. Gene Castagnini’s experience includes 15 years as a Director and Officer of Medi-Physics Inc., formerly a Hoffmann-La Roche Inc. subsidiary. Gene Castagnini has a BS in accounting and an MBA in Human Resource Management from the California State University school systems.
Follow Gene Castagnini:
About Biocare Medical: Biocare Medical is a provider of immunohistochemistry instrumentation.
Leonard Bruce Jolliff
Chief Financial Officer of Vivos Inc
Leonard Bruce Jolliff, joined Advanced Medical Isotope Corporation as Chief Financial Officer in 2006. For nine years prior to joining the Company, Mr. Jolliff was a sole practitioner in the role of CFO for Hire and as a Forensic Accountant, working with companies ranging from Fortune 500 to small family operations. Mr. Jolliff is a CPA and a member of the Washington Society of CPAs. He is also a Certified Fraud Examiner and a member of the Association of Certified Fraud Examiners. Mr. Jolliff has held CFO and Controller positions in an array of industries and has worked as a CPA in public practice. Currently all of Mr. Jolliff’s energy is focused on supporting AMI’s isotope production and securing new investments which will enable the growing company to meet it’s goals.
Follow Leonard Bruce Jolliff:
About Vivos Inc: Vivos Inc develops manufacturing equipments for the production of medical isotopes used in diagnosis and treatment of diseases.
Jeanne Henry
CFO of Excel Venture Management
Jeanne joined the Excel team in 2009 and brings more than 18 years of venture capital financial management and reporting experience to the team. Previously, Jeanne was CFO and most recently COO with Atlas Venture, an international venture firm. Earlier she was an Audit Manager with Coopers & Lybrand (now PricewaterhouseCoopers). Jeanne holds a B.A. from the University of New Hampshire, an MBA from the University of Illinois, Chicago and is a Certified Public Accountant. She is a member of the AICPA, the M.A. Society of CPA’s, and a former Board member of the Private Equity CFO Association.
Follow Jeanne Henry:
About Excel Venture Management: Excel Venture Management builds companies that apply transformative life science technologies to solve problems in healthcare and beyond.
Neil Edwards
Chief Financial Officer of Vesselon
Neil Edwards is the CEO of Cellufun. Edwards served as the founding CEO of dotMobi, a mobile web services company, where he grew the company from a start-up to a multi-million dollar organization. At dotMobi he built a global customer base with multiple channel platforms and content partners that generated significant recurring revenue streams. Additionally,Mr. Edwards was instrumental in building a consortium of leading mobile brands including Nokia, Vodafone, Google, Telefonica, Telecom Italia, T-Mobile, Orascom, Microsoft, Visa and many others. Prior to dotMobi, he was instrumental in the growth of VeriSign and infoUSA,having served in senior leadership positions within both organizations.
Follow Neil Edwards:
About Forbes, Vesselon: Vesselon is a medical device company developing novel therapeutic Immuno-Oncology complexes.
Kevin Gillis
CFO / Partner of Third Rock Ventures
Kevin Gillis joined Third Rock Ventures in 2008 and oversees the operational, financial and administrative aspects of the firm. He also directs and oversees the initial operational activities for our portfolio companies. Kevin has approximately 20 years of financial experience, successfully designing, overseeing and managing the financial operations for both newly emerging and established biotech companies. Prior to joining Third Rock Ventures, Kevin was Vice President of Finance at Coley Pharmaceutical Group, supporting the company’s successful initial public offering in 2005 and overseeing the finances related to the company’s acquisition by Pfizer in 2008. Prior to Coley, Kevin served in a number of senior finance roles at Millennium Pharmaceuticals and The Coca-Cola Company. Kevin holds an MBA from Bentley University and a BA from Brandeis University.
Follow Kevin Gillis:
About Third Rock Ventures: Third Rock Ventures invests in transformational life science companies that show high growth potential
David Ben Naim
Chief Financial Officer of Microbot Medical
Follow David Ben Naim:
About Microbot Medical: Microbot Medical is the first medical device company specialized in the researching, designing, developing and commercializing.
Terry Colip
Founder, Managing Member & CFO of Cell Point
Terry Colip, the Founder of Cell>Point, was a founding member of the firm and has provided his expertise from its inception. Mr. Colip has 26 years of expertise in investment banking and venture capital in the healthcare industry. Prior to founding Cell>Point, Mr. Colip worked as a healthcare consultant for Coopers & Lybrand in New York. He provided equity and investment banking services for roughly $2 billion in healthcare transactions at Underwood Neuhaus & Co., Boettcher & Co., and American Health Capital, Inc. Mr. Colip was also a founding partner in Chewton Glen Energy L.L.C. This company built two electric power plants in Illinois. Many media outlets, including Fox Business Network, Fox News, NBC News Denver, ABC News Denver, CBS News Denver, and National Public Radio, have highlighted Mr. Colip. Mr. Colip earned a B.S.I.E. in 1979 from the University of Wisconsin’s College of Engineering and an M.P.A. in finance and healthcare administration from New York University in 1981. Mr. Colip donates his time and resources to charities and organizations that focus on healthcare and disability outreach.
Follow Terry Colip:
About Cell Point: Cell Point is a biotechnology company developing universal molecular imaging agents and intra-nuclear metallic therapeutics.
Brian Yoor
Senior Vice President Finance & Chief Financial Officer of Abbott
Brian Yoor is Senior Vice President Finance and Chief Financial Officer. He was appointed to his current position in June 2015. He previously served as Vice President, Investor Relations. Brian joined Abbott in August 1997, and held various financial management positions of increasing responsibility, including Controller positions in the pharmaceutical, nutrition, and diagnostic businesses, before being asked to lead Abbott’s Investor Relations effort in January 2013. Prior to joining Abbott, Brian was a certified public accountant with Arthur Andersen and held financial positions in the consumer industry with the Scotts Company and Newell Rubbermaid. “In Abbott Finance, we are the stewards that enable financial reliability and growth for Abbott, “ Says Brian. “ A strong, growing company is better able to help people around the world live their healthiest lives.” Brian serves on the board of the Clara Abbott Foundation. He is a member of NIRI, the National Investor Relations Institute. He earned his bachelor’s degree in accounting at the University of Toledo in Ohio.
Follow Brian Yoor:
About Abbott: Abbott is engaged in pharmaceuticals and manufacturing healthcare products.
Thomas A. Lettero
CFO of Exact Imaging
CEO at NexGen Technology.
Follow Thomas A. Lettero:
About Exact Imaging, NexGen Technology: Exact Imaging is the developer of the ExactVu™ system, the first micro-ultrasound operating at 29 MHz that provides unmatched resolution.
Brent Faduski
CFO of SV Health Investors
Brent Faduski joined SVLS in October 2008 as Controller and focuses on finance and accounting matters for the firm. Prior Experience: Prior to joining SVLS, Brent was the Controller at CMGI @Ventures, the venture capital affiliate of CMGI, where he was responsible for the accounting and finance aspects of the firm. Prior to joining CMGI @Ventures, Brent was a Senior Associate in the Technology Group at PricewaterhouseCoopers where his clients included early stage venture backed companies as well as venture capital funds.
Follow Brent Faduski:
About SV Health Investors: SV Health Investors is a Boston-based venture capital firm focused on investments in biotechnology and healthcare industry.
Brent Faduski
CFO of SV Health Investors
Brent Faduski joined SVLS in October 2008 as Controller and focuses on finance and accounting matters for the firm. Prior Experience: Prior to joining SVLS, Brent was the Controller at CMGI @Ventures, the venture capital affiliate of CMGI, where he was responsible for the accounting and finance aspects of the firm. Prior to joining CMGI @Ventures, Brent was a Senior Associate in the Technology Group at PricewaterhouseCoopers where his clients included early stage venture backed companies as well as venture capital funds.
Follow Brent Faduski:
About SV Health Investors: SV Health Investors is a Boston-based venture capital firm focused on investments in biotechnology and healthcare industry.
Marc Naughton
EVP & CFO of Cerner
As executive vice president and chief financial officer, Marc has executive responsibility for Cerner’s financial operations and business model. Playing a key role in Cerner’s rapid rise, Marc ensures the company is growing profitably while maintaining the ability to invest heavily in future growth. Additionally, he carries responsibility for Cerner properties and legal functions, which are both large organizations that facilitate Cerner’s growth. Joining Cerner in 1992 as a finance executive and tax manager, Marc established the company’s internal tax function. He then assumed leadership of Cerner’s mergers, acquisitions and finance activities. He served as the director of finance for two years before being promoted to chief financial officer. Prior to Cerner, Marc had extensive experience in the financial industry, including at Klynveld Peat Marwick Goerdeler (KPMG) and various financial management roles at the Marley Company, a Kansas City, Missouri-based multinational manufacturing company. Marc is a certified public accountant and a member of the Kansas Bar Association. He is a past president of the Kansas City chapter of the Tax Executives Institute and a current member of the University of Kansas Finance Advisory Board. Marc earned a bachelor’s degree in business administration from Southern Methodist University and a juris doctorate from the University of Kansas.
Follow Marc Naughton:
About Cerner: Cerner is a supplier of healthcare information technology solutions, services, devices, and hardware.
Harrison Hellner
Chief Financial Officer of QGenda
As Chief Financial Officer, Hellner is responsible for building all financial operations and maintaining fiscal controls to support the company’s rapid expansion. Additionally, he is responsible for strategic partnerships and M&A. Prior to joining QGenda, Hellner spent the last six years at Raymond James Healthcare Investment Banking Group working with technology businesses to help them with a variety of capital raising activities, including debt and equity financings and M&A. He holds a B.S.
Follow Harrison Hellner:
About QGenda: QGenda is the leading innovator in enterprise healthcare workforce management solutions.
Victor Breed
Chief Financial Officer of Genoa
Victor Breed is Genoa, a QoL Healthcare Company’s Chief Financial Officer. Breed joined Genoa in October 2006. Breed is responsible for accounting functions, treasury management, billing, purchasing, insurance/risk management and banking and investor relationships. He plays a significant role in raising equity financing and negotiating new bank financing. Previously Breed was the EVP of Finance and Operations for a medical device company, ClearMedical, Inc. As the EVP, Breed developed and implemented a new business model and managed all operational and administrative functions including production, engineering, regulatory, finance, accounting, human resources and IT. Prior to ClearMedical, Inc., Breed served as Senior Vice President for Solucient, LLC. While with Solucient, he was the General Manager of the business unit providing performance management solutions for hospitals. In addition, he identified and evaluated potential business partners and M&A candidates and negotiated business relationships, joint ventures and marketing arrangements. Before working for Solucient, LLC, Breed was the COO and CFO for HBS International. As COO/CFO Breed oversaw daily operations and developed strategies for accelerating growth by merger or acquisition. HBS International was one of the Deloitte & Touche Technology Fast 500; a list of the fastest growing technology companies in North America and on the 2000 Healthcare Informatics list of 10 Most Influential Healthcare IT Companies. Breed is a graduate of Lake Superior State University with a Bachelor of Science in Accounting. He is also a member of both the American Institute of Certified Public Accountants and the Washington Society of Certified Public Accountants.
Follow Victor Breed:
About Genoa: Genoa, a QoL Healthcare Company is the pharmacy and telepsychiatry provider serving the behavioral health and addiction treatment.
Gillian Munson
Chief Financial Officer of Iora Health
Follow Gillian Munson:
About Iora Health: Iora Health is a healthcare company that helps patients manage their health and navigate the healthcare system.
Rick Kent
CFO of Paramit Corporation
Rick Kent is the Chief Financial Officer at Paramit Corporation.
Follow Rick Kent:
About Paramit Corporation: Paramit designs and manufactures medical devices and life science instruments.
Tom LaRose
CFO of Paramit Corporation
Tom LaRose is CFO at Paramit Corporation.
Follow Tom LaRose:
About Paramit Corporation: Paramit designs and manufactures medical devices and life science instruments.
Karen Adams
CFO of Arrivo BioVentures LLC
Karen Adams has a 30 year career as a finance professional working with companies across a broad range of industries with the last 15 years focused on life sciences and technology. After starting her career as an Internal Auditor with International Paper Company, Inc., Karen Adams has held financial leadership positions with companies in software, professional services and biotechnology industries. Most recently, Karen Adams has been part of the management team, in the CFO role, responsible for the creation and sale of two companies (Addrenex Pharmaceuticals to Shionogi Pharma and Neuronex to Acorda Therapeutics) and Aerial BioPharma’s ADX-N05 asset sale to Jazz Pharmaceuticals. While Karen Adams life sciences experience has been primarily focused on early-stage, privately funded companies she was brought on as Assistant Controller at Millennium Pharmaceuticals, Inc. during its merger with COR Therapeutics – among the largest such mergers in the history of the biotech industry at that time. After Millennium Pharmaceuticals, Karen Adams went on to work with several early stage biotechnology ventures including Surface Logix, Inc., Compound Therapeutics, Inc., Galenea Corporation, BG Medicine, Inc., and Micell Technologies, Inc. Karen Adams contribution was concentrated on the creation of dynamic, integrated financial forecasting models as well as the implementation of core business structure. Karen Adams graduated from Boston College earning a BS in Management, majoring in Finance.
Follow Karen Adams:
About Arrivo BioVentures LLC, Emergo Therapeutics, KJA Associates, QuatroBio: Arrivo BioVentures is a pharmaceutical development company which focuses on identifying biologics and molecules to improve patient care.
Karen Adams
CFO of Arrivo BioVentures LLC
Karen Adams has a 30 year career as a finance professional working with companies across a broad range of industries with the last 15 years focused on life sciences and technology. After starting her career as an Internal Auditor with International Paper Company, Inc., Karen Adams has held financial leadership positions with companies in software, professional services and biotechnology industries. Most recently, Karen Adams has been part of the management team, in the CFO role, responsible for the creation and sale of two companies (Addrenex Pharmaceuticals to Shionogi Pharma and Neuronex to Acorda Therapeutics) and Aerial BioPharma’s ADX-N05 asset sale to Jazz Pharmaceuticals. While Karen Adams life sciences experience has been primarily focused on early-stage, privately funded companies she was brought on as Assistant Controller at Millennium Pharmaceuticals, Inc. during its merger with COR Therapeutics – among the largest such mergers in the history of the biotech industry at that time. After Millennium Pharmaceuticals, Karen Adams went on to work with several early stage biotechnology ventures including Surface Logix, Inc., Compound Therapeutics, Inc., Galenea Corporation, BG Medicine, Inc., and Micell Technologies, Inc. Karen Adams contribution was concentrated on the creation of dynamic, integrated financial forecasting models as well as the implementation of core business structure. Karen Adams graduated from Boston College earning a BS in Management, majoring in Finance.
Follow Karen Adams:
About Arrivo BioVentures LLC, Emergo Therapeutics, KJA Associates, QuatroBio: Arrivo BioVentures is a pharmaceutical development company which focuses on identifying biologics and molecules to improve patient care.
Glenn S. Boehnlein
Chief Financial Officer & Vice President of Stryker
Follow Glenn S. Boehnlein:
About Stryker: Stryker is a medical technology company that offers products and services in orthopaedics.
Dan L. Dearen
President & Chief Financial Officer of Axonics Modulation Technologies
Follow Dan L. Dearen:
About Axonics Modulation Technologies: Axonics Modulation Technologies is a pre-revenue company developing novel implantable neuromodulation.
Susan M. Kanaya
Senior Vice President, Finance, Chief Financial Officer and Secretary of ChemoCentryx
Ms. Susan M. Kanaya has served as our Senior Vice President, Finance, and Chief Financial Officer since January 2006, and Secretary since February 2006. Prior to joining us, Ms. Kanaya served as Senior Vice President, Finance, and Chief Financial Officer at Kosan Biosciences Inc., a biotechnology company, from 1999 to 2005. Prior to this, she served in financial management positions at SUGEN, Inc., a biotechnology company, from 1994 to 1999, most recently as Vice President, Finance, and Treasurer. Ms. Kanaya also served as Controller with high technology companies and as a public accountant with KPMG. Ms. Kanaya received her B.S. in business administration from the University of California, Berkeley.
Follow Susan M. Kanaya:
About ChemoCentryx: ChemoCentryx develops orally administered small molecule therapeutics that target chemokine receptors and related chemo-attractants.
Jeff Fisher
Executive Vice President and CFO of Covenant Physician Partners
Follow Jeff Fisher:
About Covenant Physician Partners: Covenant Physician Partners is a privately-held owner and operator of ambulatory surgery centers.
Peter C. Wulff
Chief Financial Officer of JenaValve Technology
Peter C. Wulff is the chief financial officer of [JenaValve Technology](https://www.crunchbase.com/organization/jenavalve-technology#/entity), a provider of TAVI systems for transapical and transfemoral implantation. Prior to that, he was the chief financial officer and chief operating officer of Pure Bioscience. Before joining Pure Bioscience, Wulff served as the chief financial officer, vice president, and treasurer at Alphatec Spine. Previously, he was the executive vice president and chief financial officer of Artes Medical. He has also been employed at CryoCor, Ligand Pharmaceuticals, and IMED Corporation. Wulff holds a bachelor’s degree in economics and master’s degree in finance from Indiana University Bloomington. He resides in San Diego, California, United States.
Follow Peter C. Wulff:
About JenaValve Technology: JenaValve Technology develops transcatheter aortic valve implantation (TAVI) systems for transapical and transfemoral implantation.
Aaron Freidin
Chief Financial Officer of Grail
Aaron Freidin is Chief Financial Officer at Grail.
Follow Aaron Freidin:
About Grail: Grail develops a pan-cancer screening test designed to detect cancers at an early stage.
Jason Linscott
CFO of Texas Health Presbyterian Hospital Rockwall
Follow Jason Linscott:
About Texas Health Presbyterian Hospital Rockwall, Texas Health Presbyterian Hospital Rockwall: Texas Health Presbyterian Hospital Rockwall is a hospital & health care firm offering acute care services.
Michael Banks
CFO of Kineta
Michael Banks serves as the Chief Financial Officer of Kineta.
Follow Michael Banks:
About Kineta: Kineta aims at developing edge therapeutics in autoimmune disease, viral disease, and chronic pain areas.
Peter Aranow
Chief Financial Officer of Respiratory Motion
Mr. Aranow is the Chairman of Boynton Angels, a Worcester investor group that invests in start-up companies. Peter Aranow has spent 30 years in finance. For 17 years he was in the investment banking department of Bear Stearns & Co., where he worked on debt and equity financings, mergers and acquisitions, and was the investment banker responsible for Bear Stearns’ initial public offering. For the following 13 years he served as chief financial officer for a number of public and privately-owned companies, including an Internet advertising company and the New York City Off-Track Betting Corporation. Mr. Aranow holds an BA from Harvard College and an MBA from Harvard Business School.
Follow Peter Aranow:
About Harvard Business School Community Action Partners, Off Track Betting New York, Respiratory Motion: Respiratory Motion ExSpiron is FDA and CE Mark cleared and non-invasively measures minute ventilation, the fundamental unit of breathing.
Eric Davis
Chief Financial Officer of Seno Medical Instruments
Eric Davis is Chief Financial Officer of Seno Medical Instruments, Inc. Eric brings more than 26 years of financial and operational leadership with extensive domestic and international experience. He’s co-led several M&A efforts resulting in aggregate purchase prices over $500M and secured over $200M in investment capital. He’s a critical strategic thinker who also has the ability to define and implement at a tactical level. Eric was most recently the Chief Financial Officer of CeloNova BioSciences, Inc., a privately held medical device company who sold their Interventional Radiology/Oncology business to Boston Scientific at the end of 2015. Prior to CeloNova, Eric was the Chief Financial and Operating Officer at Genesis Networks Enterprises, LLC where he led the finance and accounting operations of a $1 billion network integrations and supply chain management company. Prior to Genesis, Eric spent time operating as senior finance and operations management in the Oil and Gas, Banking and Brokerage and Aero-Defense industries. Eric holds an MBA from Baylor University and BSBA in Management from the University of Tulsa. He’s also been inducted into the prestigious Beta Gamma Sigma honor society as a lifetime member and awarded Chartered Fellow (CMgr FCMI) by the Chartered Management Institute and Fellow Chartered Management Accountant (FCMA) and Chartered Global Management Accountant (CGMA) by the Chartered Institute of Management Accountants. He also holds certifications from Villanova University as a Certified Six Sigma Black Belt (CSSBB) and Certified Lean Six Sigma Sensei (CLSSS).
Follow Eric Davis:
About Seno Medical Instruments: Seno Medical is commercialization efforts in opto-acoustic imaging of breast cancer.
Douglas Larson
Group Chief Financial Officer of Beyond Air
Douglas Larson is the Group Chief Financial Officer at Beyond Air.
Follow Douglas Larson:
About Beyond Air: Beyond Air is a biotechnology company focused on the development of drugs for the treatment of lung infections.
Randy Sieve
Chief Financial Officer of HydraFacial
Randy Sieve has served as chief financial officer for HydraFacial since March 2018. Prior to joining the company, Randy held the CFO position for Columbus Manufacturing. He has over 30 years of experience, serving in positions with companies such as Central Garden & Pet Company, Diageo PLC, The Blommer Chocolate Company, Nabisco Brands, and QVC Network.
Follow Randy Sieve:
About HydraFacial: HydraFacial is an FDA registered manufacturer of advanced aesthetic technologies and products.
Paul Froutan
Chief Operating Officer & Chief Financial Officer of Xenex
Paul Froutan is the coo at Xenex Disinfection Services.
Follow Paul Froutan:
About Xenex: Xenex offers Pulsed Xenon Full Spectrum, a UV disinfection solution that reduces the bacterial load associated with the risk for HAIs.
Daniel Florin
Interim Chief Executive Officer, Senior Vice President and Chief Financial Officer of Zimmer Biomet
Dan Florin was appointed Interim Chief Executive Officer and a member of the Board of Directors on July 11, 2017. In addition, he serves as Senior Vice President and Chief Financial Officer, a position he has held since June 2015. Mr. Florin served as Senior Vice President and Chief Financial Officer of Biomet from June 2007 to June 2015.Prior to joining Biomet, Mr. Florin served as Vice President and Corporate Controller of Boston Scientific Corporation from 2001 until 2007. Before being appointed Corporate Controller in 2001, Mr. Florin served in financial leadership positions within Boston Scientific Corporation and its various business units. Prior to joining Boston Scientific Corporation, Mr. Florin worked for C.R. Bard from October 1990 through June 1995, and was employed by Deloitte from September 1986 to October 1990. Mr. Florin holds a Bachelor’s degree in Business Administration with a concentration in Accounting from the University of Notre Dame and an Executive MBA from Boston University.
Follow Daniel Florin:
About Zimmer Biomet: Zimmer Biomet designs, develops, manufactures, and markets orthopedic reconstructive and spinal products.
Steve Maiocco
Chief Financial Officer of Schooner Capital
Steve has been Schooner’s Chief Financial Officer since 1996. A Managing Director, Steve divides his time between Schooner’s internal financial and administrative matters and Schooner’s investment portfolio, including serving as a board member of Millstone Medical Outsourcing and Iron Rail Group. Prior to joining Schooner, Steve spent approximately fourteen years in public accounting at Tonneson & Company CPAs P.C. where he worked with his clients on a wide range of accounting, financial and tax matters. Steve has an undergraduate degree from Cornell University and a Master’s of Science in Taxation degree from Bentley University. He is also licensed as a Certified Public Accountant in the Commonwealth of Massachusetts.
Follow Steve Maiocco:
About Schooner Capital: Schooner Capital is a Boston-based private investment firm engaged in venture capital, growth equity, and public securities.
Mike McDonald
CFO of ThermiAesthetics
Follow Mike McDonald:
About ThermiAesthetics: ThermiAesthetics is a developer and manufacturer of thermistor-regulated energy systems for plastic surgery and dermatology applications.
John Maley
Chief Financial Officer of AliveCor
Follow John Maley:
About AliveCor: AliveCor is a FDA-cleared mobile heart solution that helps save lives, save money, and brings healthcare into the 21st century.
Laurie Silver
Chief Financial Officer of BrainScope Company
Laurie Silver has over 20 years’ experience with a financial, accounting, strategic planning and operations background. Prior to BrainScope, she served as Director of Mergers and Acquisitions for the Services group at Symantec, where she led the integration of the Services organizations upon the $13 billion merger of Symantec and Veritas, which was the largest software company merger in history. Prior to Symantec, Ms. Silver was the Vice President of Finance and Administration of TrueCareers, a subsidiary of Sallie Mae; Manager of Financial Planning and Analysis across all business units of ABC/Disney; and a Senior Auditor at Ernst & Young LLP in New York. Ms. Silver graduated from the Stephen M. Ross School of Business at the University of Michigan and earned a CPA license from the State of New York. She has been with BrainScope since 2009.
Follow Laurie Silver:
About BrainScope Company: Brainscope is a medical neurotechnology company that improves brain health.
Nathan Weems
Chief Financial Officer of VitalConnect
Nathan has accrued over 13 years of operational excellence in management roles spanning finance, business development, and marketing, most recently serving as Sr. Director of Finance at Natera, a public Bay Area biotech company. Earlier experience includes tenure at a top Wall Street investment bank and Big-4 accounting firm. Nathan brings expertise in accounting, due diligence, market research, fund raising and investor relations. He holds a BA from the University of Southern California and an MBA from Wharton. When his HP 12C is not within reach, you can usually find Nathan on two wheels or two skis exploring the outdoors with his family.
Follow Nathan Weems:
About VitalConnect: VitalConnect is a wearable biosensor technology for wireless hospital and remote patient monitoring.
David Murray
Chief Financial Officer of Alcon
Follow David Murray:
About Alcon: Alcon specializes in developing and manufacturing innovative medicines and devices to serve the full life cycle of eye care needs.
Matthew Stack
Chief Financial Officer of Koning
Matt Stack is a founder of XLP Capital, the founding manager of the Lambda Prime Investment Incubator Fund, and the Chief Investment Officer of XLP’s technology activist fund, Devonshire Capital Fund I. He is an experienced early and seed stage investor in high tech hardware and analytics companies with over $200M in completed deals, and serves as a technology advisor to a variety of institutions and family offices overseeing and directing over $500M. Over the past decade, Matt has acquired and developed a collection of minority interests in companies across North America ranging from small university spin outs to mid-sized industrial technology companies. Matt serves as an advisor to a number of privately held companies, where he manages and supervises technology and high performance computing investments. Matt has served as the Director of Computational Science at Mars Corporation and as a Partner at 3LP – a Boston-based elite Intellectual Property advisory firm. Matt’s prior experiences include managing acquisitions for a $120M corporate-led technology buyout fund in Palo Alto, as well as spending 6 years at The Boston Consulting Group in the Boston and New York offices, where he worked on projects in the Health Care, IT, Retail, Industrial Goods, and Strategy practice areas. He frequently helped corporate clients with topics including corporate growth strategy, merger and acquisitions, and post-merger integration. Before BCG, Matt co-founded and invested in a health care software startup, a small electronics company, an advanced composites design firm, and a semiconductor distribution company that traded high performance semiconductor chips between Shenzhen, Tokyo, and Tecate. Matt holds a B.S.E. in electrical engineering from Princeton University. He is a benefactor and sponsor of the TEDx conference series, and has sponsored research at the Santa Fe Institute in New Mexico, the Strategy Institute in New York, MIT’s Broad Institute, the Highlands Forum, the University of Oxford, and the Department of Defense. He is an accomplished computer hacker and cryptanalyst, and has written and advised on state-run network cyber-warfare policy, and agility-based strategic combat. Matt was recognized in 2009 by Hackaday as one of the top 10 most influential hardware hackers, and has been featured in Wired Magazine and the Wall Street Journal for his hobby electronics projects. He is the author of 11 neuroscience patents covering devices, analytical methods, and algorithms for detecting concussion and improving cognitive performance. In his spare time, he has been an Olympic hopeful in javelin, a competitive speedskater, a motorcycle collector, and is currently a professional windsurfer.
Follow Matthew Stack:
About Koning, XLP Capital: 3D Breast CT, Breast Cancer detection, Breast cancer diagnostics
Will Rousmaniere
Chief Financial Officer of Analogic
Will joined Analogic in 2012 as finance director for the company’s Ultrasound Business. In 2015 he was named senior director, financial planning and analysis. Prior to joining Analogic, Will was director of finance, precision motion and technologies at GSI Group (now Novanta), and held multiple financial leadership roles at Varian Semiconductor Equipment Associates (now a division of Applied Materials) as well as financial and operational roles at a number of technology start-ups. He earned an MBA in finance and accounting from New York University, Stern School of Business, and a BA in Economics from Cornell University and was a Certified Public Accountant.
Follow Will Rousmaniere:
About Analogic: Analogic is a technology company that develops computed tomography, ultrasound, digital mammography, and magnetic resonance imaging systems.
Jonathan Tu
CFO & Co-Founder of Fluxergy
Jonathan Tu is the Chief Financial Officer and Co-Founder at Fluxergy.
Follow Jonathan Tu:
About Fluxergy: Fluxergy is a biotechnology company that offers point-of-care testing, PCR, and medical diagnostics.
Janel Fillinger
Chief Financial Officer of Clinical Innovations
Mrs. Fillinger joined CI in September 2013 and has over 17 years of experience in financial management. She joined CI from C.R. Bard, where she held a variety of finance and management positions, most recently serving as Vice President and Controller of Bard Access Systems Division. Before her tenure with C.R. Bard, she was an auditor at Ernst & Young.
Follow Janel Fillinger:
About Clinical Innovations: Develops, manufactures and markets state-of-the-art medical devices
Genevieve Barnard
CFO & Co-Founder of MDaaS Global
Genevieve Barnard is the CFO and Co- founder of MDaaS. She used to be the associate director of associate director at Kletjian Foundation. Genevieve earned her MBA at Massachusetts Institute of Technology – Sloan School of Management.
Follow Genevieve Barnard:
About MDaaS Global: MDaaS Global operates tech-enabled diagnostic centers in clinically-underserved communities.
Heather Getz
CFO of CardioNet
Heather Getz was appointed Chief Financial Officer in January 2010. Heather joined CardioNet in May 2009 as VP of Finance, bringing years of extensive financial experience. Most recently, Heather was Vice President of Finance at Alita Pharmaceuticals, Inc., responsible for all areas of finance, accounting and information systems. Prior to Alita Pharmaceuticals, Heather held various financial leadership positions at VIASYS Healthcare Inc., including directing the company’s global financial planning, budgeting and analysis, and external reporting functions. Heather began her career at Sunoco, Inc., where she held various positions of increasing responsibility. Heather is a certified public accountant, and received her undergraduate degree in Accountancy and an MBA from Villanova University.
Follow Heather Getz:
About CardioNet, Healthy.io: CardioNet provides real-time ambulatory outpatient management solutions to monitor clinical information of people.
Steven Paladino
EVP & CFO of Henry Schein, Inc
Follow Steven Paladino:
About Henry Schein, Inc: Henry Schein, Inc. is the world’s largest provider of health care products and services to office-based dental, medical and animal health
Hodges Mauri
Vice President, Finance and Administration, Chief Financial Officer and Treasurer of Catalyst Biosciences
Ms. Hodges joined Targacept in August 2000 and currently serves as Vice President, Finance and Administration, Chief Financial Officer and Treasurer. Ms. Hodges was previously Vice President, Human Resources and Corporate Systems and served as Controller for over thirteen years. Ms. Hodges has over eighteen years of biotech and information technology industry experience in the areas of finance, audit, strategy, corporate governance, facilities management, and public company preparedness and oversight. She began her career working in public accounting with Deloitte, Haskins and Sells, and as an entrepreneur, owned and operated a certified public accounting firm for over eight years. She is a member of the World at Work organization, American Institute of Certified Public Accountants and the North Carolina Association of Certified Public Accountants. Ms. Hodges received a B.S. in Business Administration and Accounting from Virginia Polytechnic Institute and State University.
Follow Hodges Mauri:
About Catalyst Biosciences: Catalyst Biosciences is a drug R&D company creating catalytic biopharmaceutical products based on engineered human proteases.
Hodges Mauri
Vice President, Finance and Administration, Chief Financial Officer and Treasurer of Catalyst Biosciences
Ms. Hodges joined Targacept in August 2000 and currently serves as Vice President, Finance and Administration, Chief Financial Officer and Treasurer. Ms. Hodges was previously Vice President, Human Resources and Corporate Systems and served as Controller for over thirteen years. Ms. Hodges has over eighteen years of biotech and information technology industry experience in the areas of finance, audit, strategy, corporate governance, facilities management, and public company preparedness and oversight. She began her career working in public accounting with Deloitte, Haskins and Sells, and as an entrepreneur, owned and operated a certified public accounting firm for over eight years. She is a member of the World at Work organization, American Institute of Certified Public Accountants and the North Carolina Association of Certified Public Accountants. Ms. Hodges received a B.S. in Business Administration and Accounting from Virginia Polytechnic Institute and State University.
Follow Hodges Mauri:
About Catalyst Biosciences: Catalyst Biosciences is a drug R&D company creating catalytic biopharmaceutical products based on engineered human proteases.
Bob McNamara
Executive Vice President, Chief Financial Officer of LDR Holding
Bob McNamara is Executive Vice President, Chief Financial Officer. He has over twenty years experience within technology environments including medical device and software. His experience includes managing two IPO’s including Accuray Inc. ($330 million) and Somnus ($50 million). He also served as a board member post IPO for Northstar Neurosciences. During his CFO career, Bob managed six acquisitions or mergers including the acquisition of InDefense, Inc. by Microsoft Corp., the acquisition of Recourse Technologies by Symantec, and was part of the team that negotiated the $1.1B acquisition of Target Therapeutics by Boston Scientific. He holds an MBA from University of Pennsylvania’s Wharton School and a BS from University of San Francisco. Bob is a Certified Public Accountant (non-practicing) and the former Mayor of Menlo Park, California.
Follow Bob McNamara:
About LDR Holding: LDR Global Home develops and commercializes systems and instrumentation used in spine treatments and surgeries.
Fiona Lazarow
Chief Financial Officer of CTL Medical
Fiona Lazarow has more than 30 years of combined experience in financial management and the medical device industry. At CTL Medical, Lazarow is responsible for directing all financial aspects of the business, including accounting practices, budgeting, financial planning and analysis, and monitoring financial performance. Prior to joining CTL Medical, Lazarow served in executive financial roles for medical development companies, manufacturers and restaurant franchises with locations in multiple countries. Lazarow managed the accounting and worked with attorneys, outside auditors and other personnel on all levels of financial matters. Lazarow graduated from the University of Cape Town, South Africa with a Bachelor’s degree in Commerce and qualified as a Chartered Accountant in South Africa in 1984. She received her CPA license in Texas in 1986 and is a member of the American Institute of Certified Public Accountants.
Follow Fiona Lazarow:
About CTL Medical: CTL Medical Corporation assembled a world class executive team, bringing together some of the industry’s most exceptional talent.
O. James Sterling
Chief Financial Officer of Renalytix AI
Follow O. James Sterling:
About Renalytix AI: RenalytixAI is a developer of artificial intelligence (AI) enabled clinical diagnostic solutions for kidney disease.
Dan T. Bessey
CFO of Thermogenesis
Follow Dan T. Bessey:
About Thermogenesis: Thermogenesis, a health care company, focuses in development of automated technologies for cell-based therapeutics and bioprocessing.
Matthew Navarro
Chief Financial Officer of Glympse Bio
Follow Matthew Navarro:
About Glympse Bio: Glympse Bio is a biotechnology company that transforms disease detection and predict treatment response.
John Bostjancic
Chief Financial Officer of SeaSpine
John Bostjancic serves as our chief financial officer and treasurer. Prior to joining SeaSpine, Mr. Bostjancic was senior vice president of global supply chain at Integra LifeSciences from 2012 to 2014 where he was responsible for global planning, kitting, distribution, logistics and customer service functions and led the project team to comply with the FDA’s UDI rule in 2014. From 2008 to 2012, Mr. Bostjancic was senior vice president of Integra’s Financial Planning & Analysis organization. Mr. Bostjancic joined Integra in 1999 and held roles of increasing responsibility in the finance organization, including corporate controller from 2003 to 2006. Before joining Integra, Mr. Bostjancic was a manager in the Accounting Standards team at Merck & Co. Inc. and worked in the Business Assurance organization at PricewaterhouseCoopers. He received a B.A. in accounting from the College of New Jersey.
Follow John Bostjancic:
About SeaSpine: SeaSpine is a medical technology company offering spinal disorder solutions.
John Beck
Acting Chief Financial Officer of AEGEA Medical
John started BeckCFO in 2007 and brings over 30 years of experience in financial management, strategic planning and execution for technology firms. John has worked with early stage companies in life sciences (medical device and pharmaceutical), fabless semiconductor, software and software as a service, hardware systems, and services. John has held full-time CFO positions with both public and private companies, and, in addition to finance, has broad experience managing cross-functional areas such as IP management, legal, treasury, risk management, HR, IT and facilities. John’s background also includes managing the accounting, finance and reporting requirements of European and Asian offices. Before starting BeckCFO, John previously served as CFO for several companies including: Silicon Bandwidth, Inc., nDSP Corporation (acquired by PixelWorks), Sigma Designs, Inc., Augeo Software, Meta-Software, Inc. (acquired by Synopsys), Sellectek Incorporated, RayLAN Corporation, Optimem and Spectra Logic subsidiaries of Cipher Data Products, and Minton Company. Prior to his tenure at technology firms, John held senior audit positions at Ernst & Young and KPMG Peat Marwick certified public accounting firms. John earned a B.S. degree in Commerce with an Accounting emphasis, cum laude, from Santa Clara University. He is also a licensed C.P.A. (inactive), with the State of California.
Follow John Beck:
About AEGEA Medical, CloudPhysics: AEGEA Medical manufactures surgical and medical instruments.
Kevin Graff
Co-Founder, CFO of SweetBio
Follow Kevin Graff:
About FedEx, SweetBio: SweetBio is a medical device company that develops regenerative products using honey.
Michael Ellis
Director & CFO of Orange Coast Pneumatics
Michael Ellis is a Director and the CFO at Orange Coast Pneumatics Inc.
Follow Michael Ellis:
About Orange Coast Pneumatics: Orange Coast Pneumatics is a national distributor of SMC Pneumatics automation products.
Gerry Haines
Executive Vice President, Chief Financial Officer of Impulse Dynamics
Haines joined Impulse Dynamics in July 2019, bringing to the company a wealth of experience and proven track record in business, corporate finance and public markets, as well as acumen in strategic planning, M&A, and investor relations. His career has spanned a series of positions of increasing scope and responsibility. Most recently, he served as Chief Financial Officer at Mercury Systems, Inc. (NASDAQ: MRCY), where he also led Corporate Development, legal, and several other functions. Prior to Mercury, Haines served as Executive Vice President of Verenium Corporation, Executive Vice President of Strategic Affairs of Enterasys Networks, Inc., Senior Vice President of Cabletron Systems, Inc., the predecessor to Enterasys Networks; and Vice President of Applied Extrusion Technologies, Inc. Haines holds a bachelor’s degree in Business Administration, magna cum laude, from Boston University and a law degree from Cornell University.
Follow Gerry Haines:
About Impulse Dynamics: Impulse Dynamics is a medical device company dedicated to offering innovative solutions for treatment of Chronic Heart Failure (CHF).
Rene Gonzalez
Chief Financial Officer of Sanguina
Rene Gonzalez is the chief financial officer at Sanguina.
Follow Rene Gonzalez:
About Sanguina: Sanguina is a wellness and diagnostic company offering at-home anemia management tools, through app technology and an over-the-counter kit.
Lance Ream
Chief Financial Officer of Alpha Imaging
Follow Lance Ream:
About Alpha Imaging: Alpha Imaging is distributing medical imaging equipment.
Isaac Miller
CFO, Co-Founder of Cresilon, Inc.
Isaac co-founded Suneris and is responsible for all financial operations. He directs Suneris’ business initiatives and manages investor relations. Through financial analysis and forecasting, Isaac devises and implements strategic financial plans that maximize assets and foster growth at Suneris. Currently, he is an Innovation Consultant at NYU Polytechnic School of Engineering. Isaac holds a BS in Finance and Management from NYU Stern School of Business.
Follow Isaac Miller:
About Cresilon, Inc.: Cresilon is a medical device company that produces and markets solutions for trauma care.
Chuck Abdalian
CFO of Checkmate Pharmaceuticals
Follow Chuck Abdalian:
About Checkmate Pharmaceuticals: Checkmate Pharma is a clinical stage biopharmaceutical company developing a new approach for cancer immunotherapy.
Grayson Allen
CFO/COO & Co-Founder of RevBio
Grayson oversees the financial planning and reporting function as Interim CFO at Maxwell Health, and is also involved in strategic and tactical matters related to Maxwell’s continued growth. Previously, Grayson served as the CFO of a venture-backed technology company where he led a team which oversaw all financial planning and reporting, accounting, information technology, and human resources functions at the company. He played a key role in raising more than $60 million in venture capital and implemented the infrastructure necessary for rapid growth. Grayson also served as CFO for a private equity owned company engaged in the design and manufacture of bridge cranes, gantry cranes, and other custom industrial material handling solutions. While there, Grayson played an instrumental role in executing a turnaround strategy which included reducing past due receivables by 71%, managing cash flow during a period of tight liquidity, renegotiating contract terms with customers and suppliers, and assisting in the recapitalization of the ownership structure. Previously, as a Principal at the $500 million private equity arm of a leading commercial bank holding company, he was a member of the team which structured and oversaw a portfolio consisting of private equity, venture capital, and fund-of-funds investments. Grayson started his career as a commercial loan underwriter. Grayson received his B.A. in History (high honors) from Dartmouth College and his M.B.A. from the Sloan School of Management at the Massachusetts Institute of Technology. Outside of work, Grayson enjoys being outdoors and active as much as possible, and likes sailing in the summer, hiking in the fall, and running throughout the year. For many years he has collected Asian art and artifacts and has been actively collecting Japanese woodblock prints since he was 12 years old. Both Grayson and his wife Lorraine enjoy cooking together and are always interested in trying out new recipes when they have the chance.
Follow Grayson Allen:
About RevBio: RevBio was started with one goal in mind—to end medicine’s 50-year search for a biocompatible bone adhesive.
John C. Oakley
CFO of KNOW Bio
John C. Oakley is the CFO at KNOW Bio.
Follow John C. Oakley:
About KNOW Bio, Vast Therapeutics: KNOW Bio, LLC develops and produces nitric oxide-based therapies.
John C. Oakley
CFO of KNOW Bio
John C. Oakley is the CFO at KNOW Bio.
Follow John C. Oakley:
About KNOW Bio, Vast Therapeutics: KNOW Bio, LLC develops and produces nitric oxide-based therapies.
Tom Pruter
CFO of BandGrip
Previous to his involvement with Axios Investments LLC, Tom had early and instrumental involvement in a variety of startup companies across the disciplines of entertainment, new media, and educational, financial and medical technologies. Companies included therein are myFootPath, IdeaCast, K2M, OES, Tru Fragrances, Out The Box Records, Focus Technology, and TradingBlock. He is currently an active board member of TradingBlock, an online options brokerage house. Prior to focusing on early stage investing Tom was a market maker in equity options on the floor of the Chicago Board Options Exchange, covering the spectrum from sole proprietor to owning and managing several specialist operations, and still maintains a trading firm in Chicago. Tom received a BS in Computer Science from Marquette University. Upon graduation, he co-founded NeoTek Software, a developer of educational CAD/CAM software that was later integrated into a national education supplier.
Follow Tom Pruter:
About Axios Investments, Axios Investments, BandGrip, BandGrip: BandGrip is a medical noninvasive wound closure device that is used in micro-anchor skin treatment during the critical healing.
C. Evan Ballantyne
Chief Financial Officer of OncXerna Therapeutics
C. Evan Ballantyne is the chief financial officer of [Agenus](https://www.crunchbase.com/organization/agenus), a biotechnology company that develops and commercializes immunotherapies and vaccines for cancer and infectious diseases. Previously, he worked as the CEO of Synthetic Biologics. Ballantyne served as the CFO and executive vice president of Trovis Pharmaceuticals from 2006, before which he was the CFO of Knowledge Impact, ZymeQuest, Clinical Data, Velico Medical, Avalon Pharmaceuticals, and AcNielsen Corporation. Ballantyne holds a bachelor’s degree in political sciences and American history from the University of Western Ontario and a post-graduate degree in business administration from the University of Windsor.
Follow C. Evan Ballantyne:
About OncXerna Therapeutics: OncXerna Therapeutics offers precision medicine using an innovative RNA-based biomarker platform.
David Voris
CFO of Shifamed
David joined Supira Medical as Chief Financial Officer in January of 2019 and serves as the CFO for each of Shifamed’s portfolio companies. He brings over 25 years of experience in financial and operating executive leadership roles for early-stage and mid-sized medical device and life science companies. His experience includes a significant number of equity, debt, and shareholder liquidity transactions, the establishment and oversight of financial and operating controls and information systems that enable rapid scaling, and direct operational accountability. Most recently David served as CFO and COO of Optovue, Inc. a medical device company that rapidly emerged as a leader in Ophthalmology imaging. David also served as CFO for Laser Diagnostic Technologies up until its sale to Carl Zeiss Meditech. David is a certified public accountant and began his career at Deloitte in the Emerging Business Services group.
Follow David Voris:
About Atia Vision, Shifamed, Supira Medical: Shifamed is a progressive medical technology incubator that combines human-centered design.
Mike Schuh
CFO of Cardiac Insight
With almost 30 years of experience in accounting and finance., Schuh was most recently (from 2000 until 2010) Vice President, Finance and Chief Financial Officer of SonoSite Inc., the pioneer and leader of point-of-care hand-carried ultrasound. During his tenure, worldwide sales grew from $10 million to $275 million and employees from 100 to 900.
Follow Mike Schuh:
About Cardiac Insight: Cardiac Insight is a privately-held medical device company that offers body-worn ECG sensing technology.
Peter F. McAree
Senior Vice President, Chief Financial Officer & Treasurer of HeartWare International
Peter joined HeartWare in July 2012 as Chief Financial Officer with overall responsibility for the strategy and operations of the Company’s accounting and finance functions, as well as oversight of the Information Technology department. Peter has more than 25 years of financial management and public accounting experience, serving most recently as Senior Vice President and Chief Financial Officer of Caliper Life Sciences prior to their acquisition by PerkinElmer in November 2011. Before that, Peter served as CFO of Zymark Corporation prior to the company’s merger with Caliper in 2003. Peter is a Certified Public Accountant in Massachusetts, and holds a degree from Bentley University.
Follow Peter F. McAree:
About HeartWare International: HeartWare International develops and manufactures small implantable heart pumps or VAD for the treatment of advanced heart failure in US.
Jeffrey A. Baird
CFO, Secretary of CAS Medical Systems
Follow Jeffrey A. Baird:
About CAS Medical Systems: CAS Medical Systems develops non-invasive technologies and products that collect and monitor patient data in critical environments.
Christopher P. Schnittker
SVP and Chief Financial Officer of Echo Therapeutics
Mr. Schnittker brings a broad base of financial experience to Echo Therapeutics. Most recently, he served as Vice President – Administration, Corporate Secretary and Chief Accounting Officer of Soligenix, Inc., a publicly-traded biotechnology company. Prior to that, Mr. Schnittker served as the Senior Vice President and CFO for VioQuest Pharmaceuticals Inc., Micromet Inc., CytogenCorporation, and Genaera Corporation, all publicly-traded biotechnology companies. Mr. Schnittker has also held prior financial management positions at GSI Commerce, Rhône-Poulenc Rorer (now part of Sanofi-Aventis), and PricewaterhouseCoopers. He received his B.A. degree in economics and business from Lafayette College and is a certified public accountant licensed in the State of New Jersey.
Follow Christopher P. Schnittker:
About Echo Therapeutics: Echo Therapeutics develops the Symphony tCGM System, a novel, non-invasive (needle-free) glucose monitoring system for diabetes patients.
Donald Zurbay
Chief Financial Officer of Patterson Companies
Donald Zurbay became vice president, finance and chief financial officer in August 2012. Donald Zurbay joined St. Jude Medical as director of finance in 2003 and in 2004 was subsequently named corporate controller. Before coming to St. Jude Medical, Donald Zurbay worked at Deloitte and Touche LLP, The Valspar Corporation and PricewaterhouseCoopers LLP. Donald Zurbay is a member of the American Institute of Certified Public Accountants and the Minnesota Society of Certified Public Accountants. He holds a bachelor’s degree with an emphasis in accounting from the University of Minnesota.
Follow Donald Zurbay:
About Patterson Companies: Patterson Companies is an industry-leading specialty distributor serving the dental, veterinary and rehabilitation supply markets.
Kray Kibler
CFO of Safco Dental Supply
Follow Kray Kibler:
About Safco Dental Supply: Safco Dental Supply expertise in providing medical devices for dental industry.
Michael Cornelius
Chief Financial Officer of Tissuetech
Michael Cornelius joined TissueTech as Chief Financial Officer in 2014 with more than 25 years of experience in public accounting and public and private corporations. Michael Cornelius was previously with Stiefel Laboratories, serving as its Chief Financial Officer. Stiefel Laboratories was the largest privately-held dermatology company in the world, before it was acquired by GlaxoSmithKline in 2009. Mike began his career with the international accounting and consulting firm, Grant Thornton, where he specialized in US and International tax planning and also held senior level finance positions with IVAX Corporation and Sunglass Hut International. Mike holds a Bachelor of Science in Business Administration from Indiana University of Pennsylvania and is a Certified Public Accountant.
Follow Michael Cornelius:
About Tissuetech: Tissuetech offers regenerative amniotic tissue-based products for ophthalmology, optometry, musculoskeletal, and wound care markets.
Jeff Mack
CFO of Potrero Medical
Follow Jeff Mack:
About Potrero Medical: Potrero Medical is a predictive health company that is developing the next generation of smart sensors and artificial intelligence.
David Haffner
EVP , Chief Operating Officer & Chief Financial Officer of ALung Technologies
David Haffner is the EVP , Chief Operating Officer & Chief Financial Officer at ALung Technologies, Inc.
Follow David Haffner:
About ALung Technologies: ALung Technologies develops medical gas exchange devices for the treatment of acute and chronic respiratory disorders.
J. Randall Parker
Co-Founder and CFO of PharmRight
Follow J. Randall Parker:
About BAJÍO Sunglasses, PharmRight: PharmRight specializes in providing products and services that maximize medication adherence at home.
Greg Curhan
Chief Financial Officer and SVP of Corporate Development of Providence Medical Technology
Greg is an experienced corporate executive and entrepreneur, as well as a capital markets and strategic advisory expert. He brings over 30 years of experience leading and advising fast-growing companies in the medical and information technology sectors to Providence. Greg has served as Chief Financial Officer of both public and private companies. Prior to joining Providence Medical Technology Greg Curhan served as a founder and past President of Merriman Curhan Ford, a leading San Francisco-based investment bank that supported venture-backed, high-growth companies in Silicon Valley, raised over $5 billion dollars for its corporate clients and advised on numerous mergers and acquisitions. Greg is a graduate of Dartmouth College where he earned a BA in Economics and graduated Summa Cum Laude.
Follow Greg Curhan:
About Providence Medical Technology: Providence Medical Technology is a privately-held medical device company focused on innovative solutions for cervical spinal conditions.
Patrick F. Williams
Chief Financial Officer of STAAR Surgical Company
Patrick F. Williams has served as Senior Vice President and Chief Financial Officer since November 2012. Mr. Williams has nearly 20 years of financial management experience. He spent more than 5 years at NuVasive, most recently as Vice President of Strategy and Investor relations and previously as Vice President of Finance and Investor Relations. In his most recent position, he worked directly with the company’s Chief Executive Officer and senior management to develop the company’s long-term growth and operational strategy while ensuring alignment across the organization. In his previous role, Mr. Williams was responsible for the day-to-day operations of the finance department including developing the worldwide budget and forecast, identifying profitability improvements, and predicting necessary infrastructure changes to support top-line growth and operating margins. He has had responsibility for managing all aspects of NuVasive’s investor relations efforts as well as significant government affairs duties. Prior to NuVasive, Mr. Williams served as Director of Financial Planning and Analysis at Callaway Golf, where he managed the day-to-day operations of the finance department including budgeting and forecasting, companywide operational analysis and financial reporting. Prior to Callaway, he held senior finance positions at Kyocera Wireless. Mr. Williams holds an MBA in Finance and Management from San Diego State University and a Bachelor of Arts in Economics from University of California, San Diego. – See more at: http://www.coolsculpting.com/company-info/our-team#sthash.ktAIPlmR.T0uU9n32.dpuf
Follow Patrick F. Williams:
About STAAR Surgical Company: STAAR Surgical Company is at the vanguard of minimally invasive ophthalmic vision enhancement and technology.
Donald Notman
Chief Financial Officer of Ocular Therapeutix
Donald Notman brings over 20 years of financial operations and senior-level investment banking experience to Ocular Therapeutix. Prior to joining the company, Donald Notman served as Senior Vice President and Chief Financial Officer of Thrasos Therapeutics Inc., where he led the company’s financial operations, business development activities, and strategic planning functions. Previously, Donald Notman served as Managing Director and Head of Private Capital Markets for Leerink Swann LLC (now Leerink Partners), where he was involved in the build-out of the firm’s healthcare investment banking capabilities. Before joining Leerink, Donald Notman held senior level investment banking positions with Deutsche Banc Alex. Brown and Alex. Brown & Sons. Donald Notman received his M.B.A. from The Tuck School of Business at Dartmouth College and his B.A. in Economics from Middlebury College.
Follow Donald Notman:
About Ocular Therapeutix: Ocular Therapeutix develops and commercializes ophthalmic therapeutic products by using hydrogel technology.
Donald Notman
Chief Financial Officer of Ocular Therapeutix
Donald Notman brings over 20 years of financial operations and senior-level investment banking experience to Ocular Therapeutix. Prior to joining the company, Donald Notman served as Senior Vice President and Chief Financial Officer of Thrasos Therapeutics Inc., where he led the company’s financial operations, business development activities, and strategic planning functions. Previously, Donald Notman served as Managing Director and Head of Private Capital Markets for Leerink Swann LLC (now Leerink Partners), where he was involved in the build-out of the firm’s healthcare investment banking capabilities. Before joining Leerink, Donald Notman held senior level investment banking positions with Deutsche Banc Alex. Brown and Alex. Brown & Sons. Donald Notman received his M.B.A. from The Tuck School of Business at Dartmouth College and his B.A. in Economics from Middlebury College.
Follow Donald Notman:
About Ocular Therapeutix: Ocular Therapeutix develops and commercializes ophthalmic therapeutic products by using hydrogel technology.
Robert Hamilton
CFO of Vigilant Biosciences
Robert T. Hamilton currently serves as the company’s CFO. Hamilton, a former Big-Four CPA with 15+ years of public co. and venture-backed private portfolio company experience, has worked with companies in e-commerce, health and fitness, technology and retail/wholesale industries. Prior to Vigilant Biosciences, Hamilton served as CFO of Bridgevine, Inc., a privately held and venture-backed, e-commerce solution that assists Fortune 500 marketers and advertisers with new customer acquisition through a closed-loop platform. He helped Bridgevine complete a financial turnaround and grow revenues profitably to $50+MM. Previously, as CFO of eDiets, Inc. (formerly NASDAQ- DIET), a leading provider of online weight loss solutions serving over 2 million paying clients, he successfully oversaw its B2C and B2B revenues grow 25 times in a profitable manner and led the company’s transition from a self-funded private company to a NASDAQ listing. Hamilton began his career as an auditor with Arthur Andersen, LLP in Boston. Progressing to audit manager, he serviced multinational SEC and non-public clients in the high technology, manufacturing, retail/wholesale distribution, and hospitality industries. Hamilton is a Certified Public Accountant and received his Bachelors in Business Administration from Merrimack College.
Follow Robert Hamilton:
About Vigilant Biosciences: Vigilant Biosciences is a innovator and developer of solutions that aid in the early detection and intervention of cancer.
Ronald Jabba
CEO, Acting CFO of ProMed
Mr. Ronald Jabba serves as a Chief Executive Officer and Director at ProMed Inc.
Follow Ronald Jabba:
About ProMed, Zenflow: ProMed provides billing, credentialing, and contracting services in the healthcare sector.
Becky Lyne
Chief Financial Officer of Lifeline Scientific
Ms. Lyne holds more than 20 years of financial and executive management experience in a variety of industries in both the public and private markets. She has led the Lifeline Scientific, Inc. accounting function for the past 5 years as the Company’s Corporate Controller. Ms. Lyne earned her MBA in Finance from the University of Michigan and a BS in Accounting from Indiana University.
Follow Becky Lyne:
About Lifeline Scientific: Lifeline Scientific is a medical technology company, develops products and services for cell, tissue, and organ transplantation.
Scott Leffler
Chief Financial Officer of Sotera Health
Follow Scott Leffler:
About Sotera Health: Sotera Health is an integrated global health solutions provider.
William Gacki
CFO of Biothera
William Gacki is the CFO at Biothera.
Follow William Gacki:
About Biothera: Biothera is a biotechnology company developing natural gluco polysaccharides that engage and direct natural innate immune systems.
Lynn Blake
CFO of SynerFuse
Lynn is the Chief Financial Officer of SynerFuse and Executive Vice President of State Street Global Advisors (SSGA) and CIO of Global Equity Beta Solutions. In this capacity, she oversees a team of 70 portfolio managers globally, and more than 1,600 portfolios with assets in excess of $1.4 trillion across all equity index and smart beta strategies. She also oversees SSGA’s Corporate Governance and Global Proxy Voting as well as the Company Stock Group which manages fiduciary transactions and company stock investments, including company stock ownership and 401K plans. In addition, she is a member of the SSGA Fiduciary Committee, the Investment Committee, and the IT Steering Committee. Lynn also serves as a member of SSGA’s Executive Management Group. Prior to her current role, Lynn was head of non-US markets of passive equities, responsible for overseeing the management of all non-US equity index strategies, as well as serving as portfolio manager for several equity index portfolios. She joined SSGA in 1987. Lynn has a Master of Business Administration in finance from Northeastern University, and a Bachelor of Science from the Boston College Carroll School of Management. She earned the Chartered Financial Analyst (CFA) designation and is a member of the CFA Institute and the Boston Security Analyst Society. She also serves on various index advisory boards and committees.
Follow Lynn Blake:
About State Street Global Advisors, SynerFuse: SynerFuse is a provider of traditional spine implants intended to offer long-term pain management without the use of addictive opioids
John Anderson
Senior Vice President & Chief Financial Officer of Knowles Electronics
John Anderson manages all financial functions at Knowles Corporation. He plays a key role in developing, monitoring and evaluating Knowles’ overall capital structure and capital allocation strategy. Working closely with the CEO and leaders of the business units, John’s proven track record and commitment ensures Knowles consistently achieves bottom line performance, working capital, and ultimately, enhancing shareholder value. John joins Knowles after more than four years at Dover Corporation, where he held several positions. Most recently he was vice president and chief financial officer of Dover Energy, where he increased the company’s profitability through a number of acquisitions and successful integrations. Previously, John held a number of leadership titles at Sauer Danfoss, Borg Warner Turbosystems and Borg Warner Automotive. At Borg Warner, he worked in Germany for two years. He started his career with PricewaterhouseCoopers. A certified public accountant, he is member of the Illinois CPA Society and former board member of Big Brothers Big Sisters of Metropolitan Chicago. He graduated in 1986 from Western Michigan University with a Bachelor of Science degree in accounting. He also received an MBA degree in business administration from the University of Chicago in 2000. John lives in Elmhurst with his wife and three children.
Follow John Anderson:
About Knowles Electronics: Knowles Electronics is a Supplier of performance audio, intelligent audio, specialty components in the mobile communications.
Elyse Ball
Manager & CFO of Akron Ascent Innovations
In addition to her roles as CFO and secretary for AAI, Ms. Ball is assistant legal counsel to UARF. Ms. Ball holds a J.D. from Boston University and is a licensed attorney in the State of Ohio. She has substantial experience in intellectual property law and recently co-authored a book on patents for scientists and engineers. She has assisted in the formation, organization and early-stage development of several startup companies.
Follow Elyse Ball:
About Akron Ascent Innovations, The University of Akron: Based on research from the University of Akron and we remain innovators at heart.
Keith L Merrell
Chief Financial Officer of Nu-Med Plus
Mr. Merrell joined our Company in 2015 and presently holds the titles of Chief Financial Officer, Secretary and Treasurer. Mr. Merrell’s background includes over 30 years of accounting experience, holding positions as Chief Financial Officer or Controller of six companies prior to joining Nu Med Plus. In addition, his business career includes extensive experience in marketing, and mergers and acquisitions. Mr. Merrell has served as CFO for Reflect Scientific, Inc. and Controller of Specialized Health Products International, Inc., a manufacturer of safety medical devices. He also served as Vice President-Western Operations for Michelex, an injection molding company based in New York, and, similarly served as Director of Finance for The Duplication Group, where he assisted in planning, implementing, and bringing online the first compact disc manufacturing facility in the Intermountain West. Mr. Merrell holds a B.S. degree in Accounting from Arizona State University.
Follow Keith L Merrell:
About Nu-Med Plus: Nu-Med Plus is a medical device company that develops a patented technology to safely deliver precision doses of nitric oxide.
Paul Brannelly
Chief Financial Officer of Ribon Therapeutics
Follow Paul Brannelly:
About Ribon Therapeutics: Ribon Therapeutics is a biotechnology company focused on the development of therapeutics treatments targeting stress support pathways.
Tom Broetje
CFO of Monitor Mask
Tom Broetje is the Partner & Business Development of CFO Selections LLC.
Follow Tom Broetje:
About Monitor Mask, Phytelligence: Monitor Mask founded with the mission of creating capnography oxygen face masks to increase patient safety.
Chandan Srivastava
CFO & Co-Founder of Genetesis
Follow Chandan Srivastava:
About Genetesis: Genetesis is a rapidly growing medical imaging company leveraging data science and biomagnetism in the fight against cardiovascular disease
Xavier Aguilera
Executive Vice President/Chief Financial Officer of Imaging3
Mr. Aguilera has over 30 years experience in finance, marketing, international finance and administration. Having served as both a domestic and international banker, his experience in administration has enabled him to help companies achieve high levels of success. For approximately10 years prior to his employment by the Company, Mr. Aguilera served as a consultant in the medical management field. He holds a Bachelors degree in Business from California State University at Northridge and a Certificate of Medical Management from the University of California at Los Angeles.
Follow Xavier Aguilera:
About Imaging3: Imaging3 is a global manufacturer of medical devices, equipment, and imaging tools for the healthcare industry.
Mark W. Reynolds
CFO of GeoVax
Mark W. Reynolds is the CFO at GeoVax.
Follow Mark W. Reynolds:
About GeoVax: GeoVax Labs develops vaccines that prevent and fight HIV infections that result in AIDS.
Frank Patton
CFO of Nextremity Solutions
Frank is a seasoned finance professional with over 25 years of experience. During his career, he has worked in the medical products, telecommunications, software development, and foodservice distribution sectors. Mr. Patton joined Nextremity Solutions in May 2013. During his career, he has held the positions of Division CFO, Senior VP of Internal Audit, Group CFO and Division President. Prior to joining Nextremity Solutions, Mr. Patton was the Vice President of Finance for Zimmer’s Global Businesses Group with sales in excess of $1.3B. He was responsible for all finance, strategic planning and business development activities for the Trauma, Dental, Surgical and Spine business units. Complementing his medical device experience, Mr. Patton has significant experience in several aspects of operational and financial management; internal audit, strategic planning, controllership, operational finance, manufacturing accounting, credit and collections, business development and IPO’s. Mr. Patton resides in Warsaw, Indiana is married and has 2 children. He is a former board member of Florence Crittendon Services of Arizona. Frank is active member of the Institute of Management Accountants, the Financial Executives Institute and the American Institute of Certified Public Accountants.
Follow Frank Patton:
About Nextremity Solutions: Nextremity Solutions is focused on the research and product development of extremely precise and highly innovative implants.
Mark Morgan
Chief Financial Officer of PTS Diagnostics
Mr. Morgan joins PTS Diagnostics with over 25 years of global finance and administration experience in life science and medical devices. Mark will oversee all Finance and Accounting functions, as well as Human Resources. Mark brings expertise in providing strategic leadership and significant experience supporting R&D, Supply Chain, and IT with companies including Pfizer, Bayer and Mylan Pharmaceuticals. Mark holds an undergraduate degree in Accounting from Indiana State University and MBA from Illinois State University. He has been published in financial journals multiple times and has authored a book. Mark is also on the Board of Directors of the Institute of Management Accountants (IMA).
Follow Mark Morgan:
About PTS Diagnostics: PTS Diagnostics creates health innovation that drives action and connects people to improved outcomes.
